Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Salvia divinorum is a psychoactive mint plant endemic to Oaxaca, Mexico, containing the potent hallucinogen salvinorin A [PMID:33164503, PMID:33546518].
Contexte
Salvia divinorum is a perennial plant of the Lamiaceae family endemic to the southwest region of Mexico, specifically the Mazateca mountain range [PMID:33164503, PMID:30962708, PMID:33546518]. It is recognized as a source of salvinorin A, the first known non-nitrogenous, nonalkaloidal opioid-mediated psychotropic molecule [PMID:33164503, PMID:23548164].
Usages traditionnels
The plant has been used for centuries by the Mazatec people for spiritual rites, divination, medicinal purposes, and the treatment of illness associated with pain and inflammatory conditions [PMID:33164503, PMID:33546518, PMID:30962708, PMID:6876852].
Composés actifs
The main bioactive compound is salvinorin A, a neoclerodane diterpene [PMID:33164503, PMID:24315983, PMID:16213533]. Loliolide has also been identified in the plant [PMID:3701340].
Mécanisme d'action
Salvinorin A acts as a potent and highly selective agonist of the kappa-opioid receptor (KOR) [PMID:24315983, PMID:16213533, PMID:26617400, PMID:33546518]. It also exhibits allosteric modulation of cannabinoid type 1 receptors [PMID:30962708].
Preuves cliniques
Preuve DPain and Inflammation
Salvinorin A has demonstrated analgesic and anti-inflammatory effects at the cellular and molecular level [PMID:30962708]; it showed antinociceptive effects in mice with formalin-evoked trigeminal pain [PMID:40691886].
Preuve DEpilepsy
Salvinorin A ameliorated pilocarpine-induced seizures and neuronal damages in animal and in vitro models by regulating hippocampal microglia polarization [PMID:39154669].
Preuve CPsychiatric Symptoms
Use has been associated with depersonalization, paranoia, and may precipitate psychiatric symptoms or be associated with the development of psychotic disorders [PMID:26617400, PMID:17493110, PMID:26317561].
Sécurité et effets indésirables
Effects include intense hallucinations, disorientation, depersonalization, and synesthesia [PMID:23794315, PMID:18259963, PMID:15706458]. While some believe it has low toxicity and low addictive potential [PMID:26617400], it can negatively affect cognition and precipitate psychiatric symptoms [PMID:26617400].
Posologie et administration
Leaves can be chewed as a quid, drunk as an infusion, eaten raw, smoked, or vaporized [PMID:33546518, PMID:7844657]. Salvinorin A is essentially inactive if taken orally but effective in doses of 200 to 500 mcg when smoked [PMID:7844657]. Consult a healthcare provider.
Synthèse des preuves
The evidence consists primarily of reviews, case reports, and animal studies (Levels C and D). There is a lack of high-level clinical trial data (Level A or B) in humans.
Sources PubMed
1.PMID: 33164503 (2020) — DARK Classics in Chemical Neuroscience: Salvinorin A. · ACS chemical neuroscience
2.PMID: 13678554 (2003) — Hallucinogens: an update. · Current psychiatry reports
3.PMID: 24315983 (2014) — From local to global-fifty years of research on Salvia divinorum. · Journal of ethnopharmacology
4.PMID: 25653831 (2015) — Drug models of schizophrenia. · Therapeutic advances in psychopharmacology
5.PMID: 22289631 (2012) — Salvia divinorum. · Psychosomatics
6.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
PMID: 16213533 (2005) — Psychopharmacology of the hallucinogenic sage Salvia divinorum. · Life sciences
7.PMID: 26617400 (2016) — Salvia divinorum: An overview of the usage, misuse, and addiction processes. · Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists
8.PMID: 30962708 (2019) — Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action. · Journal of pain research
9.PMID: 33546518 (2021) — Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects. · Pharmaceuticals (Basel, Switzerland)
10.PMID: 3701340 (1986) — Loliolide from Salvia divinorum. · Journal of natural products
11.PMID: 39350001 (2024) — A chromosome level reference genome of Diviner's sage (Salvia divinorum) provides insight into salvinorin A biosynthesis. · BMC plant biology
12.PMID: 39154669 (2024) — Salvinorin A ameliorates pilocarpine-induced seizures by regulating hippocampal microglia polarization. · Journal of ethnopharmacology
13.PMID: 6876852 (1983) — Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.). · Journal of ethnopharmacology
14.PMID: 40565052 (2025) — Salvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential. · International journal of molecular sciences
15.PMID: 22578875 (2013) — DNA identification of Salvia divinorum samples. · Forensic science international. Genetics
16.PMID: 23548164 (2013) — Neoclerodanes as atypical opioid receptor ligands. · Journal of medicinal chemistry
17.PMID: 23794315 (2013) — Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug. · Human psychopharmacology
18.PMID: 32960103 (2020) — "Making Medicine" with Salvia divinorum: Competing Approaches and Their Implications. · Medical anthropology
19.PMID: 18259963 (2008) — Opioid receptors and legal highs: Salvia divinorum and Kratom. · Clinical toxicology (Philadelphia, Pa.)
21.PMID: 15706458 (2005) — Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage). · Pharmacopsychiatry
22.PMID: 26317561 (2015) — The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series. · Journal of psychoactive drugs
23.PMID: 24695249 (2014) — Psychoactive natural products: overview of recent developments. · Annali dell'Istituto superiore di sanita
24.PMID: 17628834 (2007) — Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology. · Planta medica
26.PMID: 32808003 (2020) — Chemical syntheses of the salvinorin chemotype of KOR agonist. · Natural product reports
27.PMID: 40691886 (2025) — Antinociceptive effect of salvinorin A from the extract of Salvia divinorum in formalin-evoked trigeminal pain behavior in mice: Underlying mechanisms. · Journal of ethnopharmacology
28.PMID: 23627785 (2013) — Salvia divinorum: a psychopharmacological riddle and a mind-body prospect. · Current drug abuse reviews
29.PMID: 7844657 (1994) — Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. · Journal of psychoactive drugs
30.PMID: 22358078 (2011) — Pharmacological activity of salvinorin A, the major component of Salvia divinorum. · Pharmacological reports : PR